Wednesday, 10 August 2011

Aromasin may prevent breast cancer recurrence

Aromasin Pills
Photo Karl Stephan

Aromasin (exemestane) can prevent new cases of breast cancer that recurs in post-menopausal women, also good to know that exemestane may soon be available in generic form as the patent expired on April 1 that would make a cheaper medication that reduces the number of newly diagnosed breast cancer.

This news is the result of a study carried out by the NCIC clinical trials group at Queen's University in Ontario, Canada, the results of the study were presented at this year's American Society of Clinical Oncology meeting in Chicago. New England Journal of Medicine published study, which ran for 5 years and includes more than 4,500 women living in North America, Spain, and France. women in the study were already menopausal and be at high risk for breast cancer.

This is not the first time that a hormonal therapy has been considered as chemoprevention for breast cancer cancer Tamoxifen is laid down in General for the many pre-and post-menopausal women after treatment for estrogen-sensitive breast cancer return of breast cancer blocking estrogen receptors, but this does not stop the estrogen production. a disadvantage of Tamoxifen, and the reason that many patients do not take it for the entire five years which is the usual regime, side effects, Tamoxifen leads to menopause-related hot flashes, night sweats and increases the risk of endometrial cancer, cataract and line.

Aromasin is milder side effects than Tamoxifen or estrogen Tamoxifen blocks differently. and Aromasin prevents estrogen production. Aromasin is a fenarimols inhibitor, which are typically awarded to post-menopausal breast cancer patients who have completed the treatment of estrogen-sensitive breast cancer drugs would benefit neither the patients who have estrogen receptor negative breast tumors, as Triple negative Breast Cancer (TNBC).

Don't rush and ask your doctor to prescribe exemestane such as breast cancer prevention just yet more studies will have to be made about its benefits and risks as well as its effectiveness in preventing the development of cancers in high-risk women. But if the research that keeps this drug can prevent many advanced mastectomies in young and old women who have had the genetic tests and found to have a strong family history and a genetic predisposition for breast cancer, cancer, for women who do not mind an early case of hot flashes in order to avoid a breast cancer tumor, side effects of exemestane seems not too bad.


View the original article here

No comments:

Post a Comment